These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 18625625

  • 1. Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination.
    Holvast A, Stegeman CA, Benne CA, Huckriede A, Wilschut JC, Palache AM, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2009 Jun; 68(6):873-8. PubMed ID: 18625625
    [Abstract] [Full Text] [Related]

  • 2. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
    [Abstract] [Full Text] [Related]

  • 3. Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis.
    Holvast A, de Haan A, van Assen S, Stegeman CA, Huitema MG, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2010 May; 69(5):924-7. PubMed ID: 19596692
    [Abstract] [Full Text] [Related]

  • 4. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.
    Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
    [Abstract] [Full Text] [Related]

  • 5. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
    Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, Guillevin L, Villiger PM.
    Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
    [Abstract] [Full Text] [Related]

  • 6. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
    Cullen G, Bader C, Korzenik JR, Sands BE.
    Gut; 2012 Mar; 61(3):385-91. PubMed ID: 21757451
    [Abstract] [Full Text] [Related]

  • 7. Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Jeffs LS, Peh CA, Jose MD, Lange K, Hurtado PR.
    Nephrology (Carlton); 2015 May; 20(5):343-51. PubMed ID: 25656094
    [Abstract] [Full Text] [Related]

  • 8. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
    Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.
    Ann Rheum Dis; 2011 Dec; 70(12):2144-7. PubMed ID: 21859696
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Holvast A, Huckriede A, Wilschut J, Horst G, De Vries JJ, Benne CA, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
    [Abstract] [Full Text] [Related]

  • 10. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
    Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, Davis JC, Ytterberg SR, St Clair EW, McCune WJ, Specks U, Allen NB, Luqmani RA, Stone JH, WGET Research Group.
    Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
    [Abstract] [Full Text] [Related]

  • 11. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [Abstract] [Full Text] [Related]

  • 12. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA, Fass DN, Specks U.
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [Abstract] [Full Text] [Related]

  • 13. Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis.
    Zycinska K, Romanowska M, Nowak I, Rybicka K, Wardyn KA, Brydak LB.
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):819-28. PubMed ID: 18204196
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Lertdumrongluk P, Changsirikulchai S, Limkunakul C, Prachukthum P, Punpiput P, Buppanharun R, Chotpitayasunondh C.
    Vaccine; 2012 Feb 01; 30(6):1108-14. PubMed ID: 22178515
    [Abstract] [Full Text] [Related]

  • 15. H1N1 vaccination in pediatric renal transplant patients.
    Kelen K, Ferenczi D, Jankovics I, Varga M, Molnar MZ, Sallay P, Reusz G, Langer RM, Pasti K, Gerlei Z, Szabo AJ.
    Transplant Proc; 2011 May 01; 43(4):1244-6. PubMed ID: 21620100
    [Abstract] [Full Text] [Related]

  • 16. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 17. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
    Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Hoffman GS.
    Arthritis Rheum; 2001 May 27; 44(5):1149-54. PubMed ID: 11352248
    [Abstract] [Full Text] [Related]

  • 18. Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis.
    Aikawa NE, Campos LM, Goldenstein-Schainberg C, Saad CG, Ribeiro AC, Bueno C, Precioso AR, Timenetsky Mdo C, Silva CA, Bonfá E.
    Scand J Rheumatol; 2013 May 27; 42(1):34-40. PubMed ID: 22992045
    [Abstract] [Full Text] [Related]

  • 19. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
    Liu LJ, Chen M, Yu F, Zhao MH, Wang HY.
    Nephrology (Carlton); 2008 Oct 27; 13(7):629-35. PubMed ID: 18775059
    [Abstract] [Full Text] [Related]

  • 20. Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.
    Woerner A, Sauvain MJ, Aebi C, Otth M, Bolt IB.
    Hum Vaccin; 2011 Dec 27; 7(12):1293-8. PubMed ID: 22185812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.